YDES

About YD Bio Limited Ordinary Shares (YDES) Stock

YD Bio Limited Ordinary Shares (YDES) closed the 2026-09-15 session at $3.95, up 3.13% versus the previous close (+0.12). The stock opened at $3.79 and traded between $3.66 and $4.04 during that session. Session trading volume was 689K shares. The volume-weighted average price (VWAP) is $3.86.

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

YD Bio Limited Ordinary Shares has a market capitalization of $279.8 million. YDES is listed on the XNAS exchange. The company employs approximately 15 people. The recorded listing date is 2025-08-29.

On this page you can find market YDES stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.